Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

CLDN1 inhibitor

DRUG CLASS:

CLDN1 inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

CLDN1 positive	Squamous Cell Carcinoma of Head and Neck	CLDN1 positive	Squamous Cell Carcinoma of Head and Neck	ALE.C04 Sensitive: B - Late Trials ALE.C04 Sensitive : B	ALE.C04 Sensitive: B - Late Trials ALE.C04 Sensitive : B
VEGFB expression	Hepatocellular Cancer	VEGFB expression	Hepatocellular Cancer	CLDN1 inhibitor Resistant: D – Preclinical CLDN1 inhibitor Resistant : D	CLDN1 inhibitor Resistant: D – Preclinical CLDN1 inhibitor Resistant : D
CLDN1 overexpression	Solid Tumor	CLDN1 overexpression	Solid Tumor	ALE.C04 Sensitive: D – Preclinical ALE.C04 Sensitive : D	ALE.C04 Sensitive: D – Preclinical ALE.C04 Sensitive : D